Bruno Geloneze
Bruno Geloneze is a prominent endocrinologist and the principal researcher at the Obesity and Comorbidities Research Center (OCRC) at the State University of Campinas (Unicamp), known for his expertise in obesity treatment and his evaluation of the comparative efficacy and safety of medications like tirzepatida and semaglutida.
Not in the pool (under ¢1).
Recent news mentions
Bruno Geloneze is an endocrinologist who discusses the dangers of alcohol consumption while using certain medications.
vai beber e usa canetas emagrecedoras? Médicos alertam para os riscos dessa combinação explosiva
Brazil· 2026-02-13
Bruno Geloneze is the principal researcher at the Center for Research in Obesity and Comorbidities.
Estudo analisa riscos e benefícios de remédios da classe do Ozempic; efeito no cérebro é destaque
Liechtenstein· 2025-03-18
Bruno Geloneze is the principal researcher at the Center for Research in Obesity and Comorbidities at the University of Campinas and discusses the complexities of weight loss promotion.
Mounjaro supera Wegovy em perda de peso de paciente com obesidade, diz farmacêuticaLiechtenstein· 2025-03-18